Day One Biopharmaceuticals (DAWN) December 10 and 11 calls active
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts DAWN Hot Sheet
Join SI Premium – FREE
Day One Biopharmaceuticals (NASDAQ: DAWN) 30-day call option implied volatility is at 141; compared to its 52-week range of 44 to 178 with a focus on December 10 and 11 calls as share price up 8.2%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue Airways (JBLU) Misses Q3 EPS by 6c, Misses on Revenue
- Park National Corp. (PRK) Tops Q3 EPS by 6c
- Life Time Group Holdings Inc (LTH) PT Raised to $68 at Mizuho, 'Attractive Entry'
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
